Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer
Xinpeng Li(Qilu Hospital of Shandong University), Yi-Qing Qu(Qilu Hospital of Shandong University)
Cited by 8
Related Papers
Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models
|Journal of Experimental & Clinical Cancer Research|2014|47
Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma
|Journal of Translational Medicine|2022|16
IDO1 Promotes the Progression of NSCLC by Regulating the Polarization of M2 Macrophages
|International Journal of General Medicine|2023|11